Analysis of the consistency of intraurethral prostaglandin E1 (MUSE) during at-home use

Urology

Volumn 58, Issue 2, 2001, Pages 262-266

  Mulhall, John P ^a   Jahoda, Andrew E ^a   Ahmed, Absaar ^a   Parker, Marilyn ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ERECTILE DYSFUNCTION; FOLLOW UP; HOME CARE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OFFICE WORKER; PATIENT EDUCATION; PENIS ERECTION; PHYSICIAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ALPROSTADIL; ANALYSIS OF VARIANCE; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SUPPOSITORIES; TREATMENT OUTCOME; URETHRA;

EID: 0034910026     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01164-5     Document Type: Article

References (20)

1. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study
2. The epidemiology of erectile dysfunction: Results from the National Health and Social Life Survey
3. Sexual dysfunction in the United States: Prevalence and predictors
4. Treatment of men with erectile dysfunction with transurethral alprostadil
5. Transurethral alprostadil administration with MUSE: Current overview and personal experiences
6. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy
7. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy
8. Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea
9. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil - A comparative study in 103 patients with erectile dysfunction
10. Intracavernosal versus intraurethral alprostadil: A prospective randomized study
11. Hemodynamic effects of transurethral alprostadil measured by color duplex ultrasonography in men with erectile dysfunction
12. Physiology of erection and pharmacological management of impotence
13. The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners
14. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction
15. Intracavernous injection therapy for male erectile dysfunction
16. MUSE therapy: Preliminary clinical observations
17. The causes of patient drop-out from a penile self-injection therapy for impotence
18. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction
19. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction
20. Oral sildenafil in the treatment of erectile dysfunction